$VICR

VINCIARELLI PATRIZIO sold $6.7M of VICR

VINCIARELLI PATRIZIO (Chairman & CEO) sold 20,000 shares of VICOR CORP (VICR) at an average of $337.45 ($326.68–$347.07, $6.75M total) across 18 trades on 2026-06-23 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · VINCIARELLI PATRIZIO
Published Jun 25, 2026, 2:47 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 25, 2026, 2:49 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$VICR
Neutral
medium confidence
Mentioned
$VICR
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VICRNeutralLow
01

Why it matters

The newest actionable element is the disclosed sale size ($6.75M) and the fact it was executed under a pre-arranged plan, which generally lowers informational content but can still affect short-term sentiment.

02

Market read

Traders may monitor for follow-on insider activity or changes in selling/buying patterns, but this specific disclosure is unlikely to drive a major repricing alone.

03

What to watch

The filing does not disclose reasons for the sale or any concurrent operational updates; traders should weigh the insider’s remaining holdings (8.49M shares) and the scheduled nature of the trades.

Relevance 5/10Novelty 6/10Timing: SEC Form 4 filed 2026-06-25 for sales executed 2026-06-23

Background

The article is an SEC Form 4 insider transaction: VICR’s Chairman & CEO (Vinciareli Patrizio) sold shares across 18 trades on 2026-06-23 under a Rule 10b5-1 plan.

Company-level read

Ticker impact

$VICRNeutralMedium confidence
Context

VICR’s CEO/Chairman sold about $6.75M of VICR shares via an open-market sale under a pre-arranged 10b5-1 plan on 2026-06-23.

Expected impact

Near-term: limited downside bias from optics; likely muted impact given 10b5-1 pre-arrangement.

Evidence & confidence

The filing specifies a Rule 10b5-1 plan and open-market sale, which typically reduces the signal of new negative information versus discretionary selling.

Market effects

No sector-wide read-across; this is a single-company insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Because the sale is under a pre-arranged 10b5-1 plan, the market may overreact to the headline size; the transaction could be routine liquidity rather than a view on fundamentals.

Key entities

  • VICOR CORP

    Company whose insider transaction is disclosed on SEC Form 4.

  • VINCIARELLI PATRIZIO

    Chairman & CEO and 10% owner who executed the open-market sales.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$MXLHighAI 8/10

MXL vs. VICR: Which Has the Better AI Infrastructure Opportunity?

MaxLinear (MXL) and Vicor (VICR) are positioned to benefit from AI infrastructure growth. MXL reported 55% revenue growth in Q2 2026, driven by optical and electrical interconnects. Vicor focuses on power delivery for AI processors. MXL's AI products, like Keystone and Rushmore, are in high demand, with new products expected to launch in 2027 and 2028.

$VICRMedAI 8/10

Vicor (VICR) Q2 2026 Earnings Call Transcript

Vicor’s Q2 2026 earnings call reported product and royalty revenue of $143.4M, up 26.9% sequentially and 1.6% year over year. Advanced products revenue rose to $94.2M. Net income was $49.8M, GAAP diluted EPS $1.40, and cash was $453.6M. The company guided for nearly 10% Q3 revenue growth and over $600M 2026 revenue, citing capacity increases and licensing assumptions.

$VICRMed

Vicor Corp (VICR) Q2 2026 Earnings Call Highlights: Strong Revenue Growth

Vicor Corp said a new license agreement will bring $5 million quarterly payments in year one and $10 million in year two, with $15 million contributing to Q2 revenue and additional revenue recognition expected in Q3 and subsequent quarters. Management also discussed fab capacity expansion to support a $2.5 billion revenue goal and said backlog growth stems mainly from existing customer demand.

$VICRMed

VICOR CORP (VICR): Results of Operations and Financial Condition

VICOR CORP (VICR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d115827dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 NEWS RELEASE FINANCIAL NEWS BRIEF July 21, 2026 For Immediate Release Vicor Corporation Reports Results for the Second Quarter Ended June 30, 2026 Andover, Mass., July 21, 2026 (GLOBE NEWSWIRE) — Vicor Corporation (NASDAQ: